financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program
May 22, 2024 8:02 AM

10:33 AM EDT, 05/22/2024 (MT Newswires) -- MaxCyte ( MXCT ) said Wednesday it has signed a strategic platform license agreement with Legend Biotech ( LEGN ) to support Legend Biotech's ( LEGN ) cell therapy program.

Under the terms of the agreement, Legend Biotech ( LEGN ) obtained a non-exclusive worldwide license to use MaxCyte's ( MXCT ) Flow Electroporation technology and ExPert platform for the research, development, and commercialization of cell therapy products, MaxCyte ( MXCT ) said.

In return, Legend Biotech ( LEGN ) will pay MaxCyte ( MXCT ) annual licensing fees and milestones during clinical development as well as royalties on net sales of licensed products, MaxCyte ( MXCT ) said.

Shares of MaxCyte ( MXCT ) were 3.8% higher in recent Wednesday trading, and Legend Biotech ( LEGN ) shares were 1.5% up.

Price: 4.80, Change: +0.18, Percent Change: +3.79

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aditxt Files $100 Million Mixed Shelf
Aditxt Files $100 Million Mixed Shelf
Jul 11, 2024
05:19 PM EDT, 07/11/2024 (MT Newswires) -- Aditxt ( ADTX ) filed a shelf registration statement with the US Securities and Exchange Commission Thursday covering the potential sale of up to $100 million of securities from time to time in one or more offerings. The statement covers common and preferred stock, debt securities, warrants, rights and units, according to a...
 KalVista Pharmaceuticals Files $300 Million Mixed Shelf
KalVista Pharmaceuticals Files $300 Million Mixed Shelf
Jul 11, 2024
05:19 PM EDT, 07/11/2024 (MT Newswires) -- KalVista Pharmaceuticals ( KALV ) filed a registration statement Thursday covering the potential sale of up to $300 million of its securities from time to time. The filing covers common stock, preferred stock, debt securities, warrants, subscription rights and units. The company plans to use the net proceeds for general corporate purposes. Price:...
 Eldorado Gold Edging Up After Hours as it Flags Lower Tax Impacts in Turkiye
Eldorado Gold Edging Up After Hours as it Flags Lower Tax Impacts in Turkiye
Jul 11, 2024
05:25 PM EDT, 07/11/2024 (MT Newswires) -- Eldorado Gold ( EGO ) edged up in after-hours New York trade Thursday as it provided updates on the tax impacts in Turkiye for the second quarter. According to a statement, the company's profits from mining operations in Turkiye are taxed at the enacted rate and the resulting current income tax expense can...
 Astronics Expands Revolver, Refinances Term Loan
Astronics Expands Revolver, Refinances Term Loan
Jul 11, 2024
05:16 PM EDT, 07/11/2024 (MT Newswires) -- Astronics ( ATRO ) said late Thursday it expanded its revolving line of credit to $200 million from $115 million and refinanced its term loan. The company said it had $128 million drawn on the facility at closing. The refinancing consists of an expanded asset-based line of credit and a reduced, lower-cost term...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved